Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial https://t.co/geP58qKvm0 #ScientiaVH
2,356 followers
806 followers
Adding bevacizumab to chemotherapy improved response rates and progression-free survival in rel/ref neuroblastoma, with acceptable toxicity 🎗️🔬 #Neuroblastoma #BEACON trial https://t.co/RiLn7vu2dO
50,405 followers
Promising activity seen for bevacizumab, irinotecan and temozolomide in #neuroblastoma: https://t.co/KJw5krxerI @CCBD_VHResearch
675 followers
RT @CCBD_VHResearch: Promising results for relapsed high-risk neuroblastoma in ITCC-SIOPEN BEACON Trial! Dr.Lucas Moreno, head of our group…